agilon health, inc. is a healthcare services company that partners with independent primary care physicians to transition their practices to value-based care models. Operating primarily in the United States, the company focuses on seniors enrolled in Medicare Advantage plans. agilon provides the technology platform, capital, and business expertise necessary for physician groups to form risk-bearing entities and manage the total healthcare needs of their patients under global capitation arrangements.
Financial Statements
In thousands, USD
FY 2025
FY 2024
FY 2023
FY 2022
Total Revenues
5,932,576
6,060,530
4,316,363
2,388,220
Cost of Sales
6,092,597
6,055,689
4,246,693
2,276,860
Gross Profit
(160,021)
4,841
69,670
111,360
Selling, General & Administrative Expenses
238,536
268,912
285,760
207,789
Depreciation & Amortization Expenses
28,594
24,463
16,043
8,949
Other Operating Expenses
36,085
3,596
—
—
Operating Profit
(463,236)
(292,130)
(232,133)
(105,378)
Interest and Investment Income
(1,835)
14,992
16,489
10,720
Interest Expense
(6,641)
(6,177)
(6,658)
(4,484)
Non-Operating Income
67,616
34,489
27,840
8,472
Total Non-Operating Income
59,140
43,304
37,671
14,708
Income Before Provision for Income Taxes
(404,096)
(248,826)
(194,462)
(90,670)
Provision for Income Taxes
1,251
1,451
791
1,640
Consolidated Net Income
(405,347)
(250,277)
(195,253)
(92,310)
Net Income Attributable to Minority Interests and Other
—
(50)
207
311
Net Income Attributable to Discontinued Operations
14,000
(9,824)
(67,550)
(14,554)
Net Income Attributable to Common Shareholders
(391,347)
(260,151)
(262,596)
(106,553)
Basic EPS
-24.50
-15.25
-12.00
-5.50
Diluted EPS
-24.50
-15.25
-12.00
-5.50
Basic Weighted Average Shares Outstanding
16,559
16,439
16,357
16,326
Diluted Weighted Average Shares Outstanding
16,559
16,439
16,357
16,326
Shares Outstanding
16,589
16,488
16,255
16,495
FY 2025
FY 2024
FY 2023
FY 2022
Cash and Cash Equivalents
173,713
188,231
107,570
465,302
Short-Term Investments
111,429
211,737
380,773
411,901
Total Cash and Cash Equivalents
285,142
399,968
488,343
877,203
Accounts Receivable
673,793
1,017,040
942,461
492,364
Total Trade Receivables
673,793
1,017,040
942,461
492,364
Other Current Assets
137,762
40,766
49,272
81,707
Total Current Assets
1,096,697
1,457,774
1,480,076
1,451,274
Net Property, Plant & Equipment
25,417
28,169
27,576
19,937
Net Intangible Assets
65,725
72,771
63,769
18,448
Goodwill
—
24,133
24,133
2,513
Other Long-Term Assets
83,451
151,136
145,312
205,296
Total Assets
1,271,290
1,733,983
1,740,866
1,697,468
Accounts Payable
127,477
220,342
239,432
177,428
Accrued Expenses
929,770
931,664
737,724
300,798
Short-Term Debt
—
—
—
5,000
Current Portion of Long-Term Debt
19,238
—
—
—
Other Current Liabilities
—
—
—
51,865
Total Current Liabilities
1,076,485
1,152,006
977,156
535,091
Long-Term Debt
15,750
34,904
32,308
38,482
Other Long-Term Liabilities
52,321
76,121
70,381
83,286
Total Long-Term Liabilities
68,071
111,025
102,689
121,768
Total Liabilities
1,144,556
1,263,031
1,079,845
656,859
Common Stock
4,147
4,122
4,064
4,124
Additional Paid-in Capital
2,099,995
2,053,895
1,986,899
2,106,886
Accumulated Other Comprehensive Income
916
(88)
(2,298)
(5,560)
Retained Earnings
—
—
(1,326,826)
(1,064,230)
Total Common Shareholders' Equity
2,105,058
2,057,929
661,839
1,041,220
Minority Interests and Other
—
—
(818)
(611)
Total Shareholders' Equity
2,105,058
2,057,929
661,021
1,040,609
Total Liabilities and Shareholders' Equity
1,271,290
1,733,983
1,740,866
1,697,468
FY 2025
FY 2024
FY 2023
FY 2022
Net Income
(391,347)
(260,101)
(262,803)
(106,864)
Depreciation & Amortization
28,594
24,463
20,161
13,772
Share-Based Compensation Expense
49,119
50,657
69,495
28,381
Other Adjustments
18,402
(6,981)
27,015
(6,662)
Changes in Trade Receivables
344,585
(74,580)
(460,365)
(204,167)
Changes in Accounts Payable
(85,585)
4,635
32,111
65,736
Changes in Other Operating Activities
(69,531)
200,534
418,187
78,996
Cash from Operating Activities
(105,763)
(57,777)
(156,199)
(130,808)
Capital Expenditure
(13,242)
(13,251)
(15,830)
(15,426)
Purchases of Intangible Assets
(29,866)
(28,034)
(14,985)
(17,235)
Purchases of Investments
(60,154)
(12,006)
(114,657)
(458,265)
Proceeds from Sale of Investments
193,872
206,915
164,040
52,548
Payments for Business Acquisitions
—
—
(45,252)
—
Proceeds from Business Divestments
—
—
2,193
500
Other Investing Activities
(2,000)
(13,733)
(19,528)
(6,510)
Cash from Investing Activities
88,610
139,891
(44,019)
(444,388)
Repayments of Long-Term Debt
—
(3,750)
(5,000)
(5,000)
Net Issuance / (Repayments) of Long-Term Debt
—
(3,750)
(5,000)
(5,000)
Issuance of Common Shares
(2,994)
1,167
11,867
33,056
Repurchases of Common Shares
—
—
(200,000)
—
Net Issuance / (Repurchases) of Common Shares
(2,994)
1,167
(188,133)
33,056
Cash from Financing Activities
(2,994)
(2,583)
(193,133)
28,056
Increase / (Decrease) in Cash, Cash Equivalents and Restricted Cash